Solange Carrasco

Prof. Solange Carrasco

Faculdade de Medicina da Universidade de São Paulo, Pacaembu, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2015 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
JCJin‐Young Choi
Jin‐Young Choi
JHJohn Hsi‐En Ho
John Hsi‐En Ho
SPSandra G. Pasoto
Sandra G. Pasoto
VBViviane Bunin
Viviane Bunin
SKSang Taek Kim
Sang Taek Kim
JCJoseph Craft
Joseph Craft
Objective: To assess circulating follicular helper T (Tfh)–like CD4+ T cells in patients with systemic lupus erythematosus (SLE) and determine their relationship to disease activity.Methods: Blood samples from patients with SLE, as well as blood samples from patients with Behçet's disease (BD) and healthy individuals as controls, were analyzed. In all samples, circulating Tfh‐like cells were enumerated by flow cytometry, using, as markers, expression of CXCR5, inducible T cell costimulator (ICOS), and programmed death 1 (PD‐1) protein, as well as secretion of interleukin‐21 (IL‐21). The frequency of circulating Tfh‐like cells was compared to that of circulating plasmablasts (CD19+IgD−CD38+). In addition, the possible association of circulating Tfh‐like cells with the SLE Disease Activity Index (SLEDAI) was evaluated.Results: The subset of circulating Tfh‐like T cells, identified as CXCR5highICOShighPD‐1high, was expanded in the blood of SLE patients compared to controls. Circulating Tfh‐like cells were found to produce IL‐21 and had lower expression of CCR7 as compared to that in circulating CXCR5high central memory T cells, thereby enabling their distinction. Expression of PD‐1, but not ICOS or CXCR5, was significantly elevated in circulating Tfh‐like cells from SLE patients compared to controls. PD‐1 expression among CXCR5high circulating Tfh‐like cells correlated with the SLEDAI, frequency of circulating plasmablasts, and anti–double‐stranded DNA antibody positivity, but not with disease duration or past organ injury; rather, this cell profile appeared to be a reflection of current active disease.Conclusion: Circulating Tfh‐like cells are associated with disease activity in SLE, suggesting that their presence indicates abnormal homeostasis of T cell–B cell collaboration, with a causal relationship that is central to disease pathogenesis. These findings also suggest that circulating Tfh‐like cells provide a surrogate for aberrant germinal center activity in SLE, and that their PD‐1 expression offers a tool for measuring disease activity and monitoring the response to therapies.

25 August 2009 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
FNFabricio Souza Neves
Fabricio Souza Neves
SCSolange Carrasco
Solange Carrasco
CGCláudia Goldenstein-Schainberg
Cláudia Goldenstein-Schainberg
CGCélio Roberto Gonçalves
Célio Roberto Gonçalves
SMSuzana Beatriz Veríssimo de Mello
Suzana Beatriz Veríssimo de Mello

1 March 2003 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
WOWalmar Roncalli Pereira de Oliveira
Walmar Roncalli Pereira de Oliveira
SCSolange Carrasco
Solange Carrasco
CNCyro Festa Neto
Cyro Festa Neto
PRPeter Rady
Peter Rady
STStephen K. Tyring
Stephen K. Tyring

1 February 2010 in Human Pathology
Verified
Journal Article
Closed access
PSPaola Souza
Paola Souza
FRFabrizio Rizzardi
Fabrizio Rizzardi
GNGustavo Noleto
Gustavo Noleto
MAMarcelo Atanazio
Marcelo Atanazio
OBOsmar Bianchi
Osmar Bianchi
VERA CAPELOZZIVERA CAPELOZZI
VERA CAPELOZZI

1 January 2000 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
BLBernadete L. Liphaus
Bernadete L. Liphaus
MKMaria H. B. Kiss
Maria H. B. Kiss
SCSolange Carrasco
Solange Carrasco
CGClaudia Goldenstein-Schainberg
Claudia Goldenstein-Schainberg
Defective regulation of apoptosis may play a role in the development of autoimmune diseases. Fas and Bcl-2 proteins are involved in the control of apoptosis. The aims of this study were to determine the expression of Fas antigen and Bcl-2 protein on peripheral blood T and B lymphocytes from patients with juvenile-onset systemic lupus erythematosus (JSLE), juvenile rheumatoid arthritis (JRA) and juvenile dermatomyositis (JDM). Thirty-eight patients with JSLE, 19 patients with JRA, 10 patients with JDM and 25 healthy controls entered the study. Freshly isolated peripheral blood mononuclear cells (PBMC) were stained for lymphocyte markers CD3, CD4, CD8, CD19 and for Fas and Bcl-2 molecules. Expressions were measured by three-color flow cytometry. Statistical analysis was performed using Kruskal–Wallis test. Percentages of freshly isolated T lymphocytes positively stained for Fas protein from JSLE patients were significantly increased compared to healthy controls, patients with JRA and patients with JDM. Percentages of B lymphocytes positive for Fas from JSLE patients were higher than healthy controls and JRA patients. In addition, Fas expression on T cells from patients with JRA was increased compared to JDM patients. Otherwise, Fas expression on T and B cells from JRA and JDM patients were similar to healthy controls. MFI of Bcl-2 positive T lymphocytes from JSLE patients were significantly increased compared to healthy controls and JRA patients. MFI of Bcl-2 protein on B lymphocytes from JSLE patients was similar to healthy controls and patients with JRA and JDM. Bcl-2 expression did not differ between JRA and JDM patients and healthy controls. In conclusion, increased expression of Fas and Bcl-2 proteins observed in circulating T and B lymphocytes from patients with JSLE, but not from patients with JRA and JDM, suggests that abnormalities of apoptosis may be related to the pathogenesis of JSLE and probably are not a result of chronic inflammation.

1 November 2011
Verified
Journal Article
Closed access
SCSolange Carrasco
Solange Carrasco
FNF. S. Neves
F. S. Neves
MFM. H. Fonseca
M. H. Fonseca
CGC. R. Goncalves
C. R. Goncalves
CSC. G. Saad
C. G. Saad
CGC. Goldenstein-Schainberg
C. Goldenstein-Schainberg